VirtualScopics Inc  

(Public, NASDAQ:VSCP)   Watch this stock  
Find more results for VSCP
0.590
-0.020 (-3.28%)
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.56 - 0.61
52 week 0.49 - 1.09
Open 0.60
Vol / Avg. 0.00/19,601.00
Mkt cap 17.55M
P/E     -
Div/yield     -
EPS -0.09
Shares 29.75M
Beta 0.87
Inst. own 23%
Aug 12, 2013
Q2 2013 VirtualScopics, Inc. Earnings Release Add to calendar
May 15, 2013
Q1 2013 VirtualScopics, Inc. Earnings Conference Call
May 13, 2013
Q1 2013 VirtualScopics, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin -2.38% 4.92%
Operating margin -1.60% 0.33%
EBITD margin - 3.45%
Return on average assets -2.43% 6.90%
Return on average equity -4.26% 9.72%
Employees 96 -
Carbon Disclosure Rating - -

Address

500 Linden Oaks
ROCHESTER, NY 14625
United States - Map
+1-585-2496231 (Phone)
+1-585-2187350 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

VirtualScopics, Inc.(VirtualScopics, Inc) is a provider of quantitative imaging for clinical trials serving the pharmaceutical, biotechnology and medical device industries. It has created a range of image analysis software tools and applications, which are used in detecting and measuring anatomical structures and metabolic activity using medical images. The Company�s image-based measurement and visualization tools enable automated, accurate and reproducible measurement of minute changes that occur in anatomic structures in musculoskeletal, oncological, cardiological and neurological diseases. The Company provides blood flow and volume measurements for cancer diagnosis and monitoring in a standardized and consistent way across multiple institutions. These measurements are vital for assessing patient response to anti-angiogenic cancer drugs.

Officers and directors

Robert G. Klimasewski Independent Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
L. Jeffrey Markin President, Chief Executive Officer, Chief Operating Officer, Director
Age: 53
Bio & Compensation  - Reuters
Molly Henderson Chief Business and Financial Officer, Senior Vice President
Age: 41
Bio & Compensation  - Reuters
Mostafa Analoui Ph.D. Independent Director
Age: 51
Bio & Compensation  - Reuters
Daniel I. Kerpelman Independent Director
Age: 53
Bio & Compensation  - Reuters
Norman N Mintz Ph.D. Independent Director
Age: 77
Bio & Compensation  - Reuters
Charles E. Phelps Ph.D. Independent Director
Age: 69
Bio & Compensation  - Reuters
David Rubin Ph.D. Independent Director
Age: 47
Bio & Compensation  - Reuters